These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27197055)

  • 1. Higher Gemcitabine Dose Was Associated With Better Outcome of Osteosarcoma Patients Receiving Gemcitabine-Docetaxel Chemotherapy.
    Lee JA; Jeon DG; Cho WH; Song WS; Yoon HS; Park HJ; Park BK; Choi HS; Ahn HS; Lee JW; Yoo KH; Sung KW; Koo HH; Kang HJ; Park KD; Shin HY; Koh KN; Im HJ; Seo JJ; Lim YJ; Baek HJ; Kook H
    Pediatr Blood Cancer; 2016 Sep; 63(9):1552-6. PubMed ID: 27197055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine and docetaxel for the treatment of children and adolescents with recurrent or refractory osteosarcoma: Korea Cancer Center Hospital experience.
    Song BS; Seo J; Kim DH; Lim JS; Yoo JY; Lee JA
    Pediatr Blood Cancer; 2014 Aug; 61(8):1376-81. PubMed ID: 24692087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma.
    Lee JA; Paik EK; Seo J; Kim DH; Lim JS; Yoo JY; Kim MS
    Jpn J Clin Oncol; 2016 Feb; 46(2):138-43. PubMed ID: 26685322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.
    Qi WX; He AN; Tang LN; Shen Z; Lin F; Yao Y
    Jpn J Clin Oncol; 2012 May; 42(5):427-31. PubMed ID: 22450929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma.
    Navid F; Willert JR; McCarville MB; Furman W; Watkins A; Roberts W; Daw NC
    Cancer; 2008 Jul; 113(2):419-25. PubMed ID: 18484657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma.
    Xiao X; Wang W; Wang Z
    Paediatr Drugs; 2014 Dec; 16(6):503-12. PubMed ID: 25392156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience.
    He A; Qi W; Huang Y; Sun Y; Shen Z; Zhao H; Yang Y; Yao Y
    Int J Clin Oncol; 2013 Jun; 18(3):498-505. PubMed ID: 22534798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial.
    Binder D; Schweisfurth H; Grah C; Schäper C; Temmesfeld-Wollbrück B; Siebert G; Suttorp N; Beinert T
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):143-50. PubMed ID: 17031643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.
    Fox E; Patel S; Wathen JK; Schuetze S; Chawla S; Harmon D; Reinke D; Chugh R; Benjamin RS; Helman LJ
    Oncologist; 2012; 17(3):321. PubMed ID: 22363068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre-clinical study.
    Low K; Foulkes P; Hills F; Roberts HC; Stordal B
    Cancer Med; 2024 Sep; 13(18):e70248. PubMed ID: 39315544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine with or without docetaxel and resection for recurrent osteosarcoma: the experience at Children's Memorial Hospital.
    Gosiengfiao Y; Reichek J; Woodman J; Ben-Ami T; Walterhouse D
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):e63-5. PubMed ID: 22217487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients.
    Tanaka K; Joyama S; Chuman H; Hiraga H; Morioka H; Yoshikawa H; Hosaka M; Takahashi M; Kubo T; Hatano H; Kaya M; Toguchida J; Nishida Y; Nagano A; Tsumura H; Iwamoto Y
    World J Surg Oncol; 2016 Dec; 14(1):306. PubMed ID: 27931230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel.
    Mora J; Cruz CO; Parareda A; de Torres C
    J Pediatr Hematol Oncol; 2009 Oct; 31(10):723-9. PubMed ID: 19727011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma.
    Lee EM; Rha SY; Lee J; Park KH; Ahn JH
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):635-42. PubMed ID: 21959979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 study.
    Hara H; Kawamoto T; Fukase N; Kawakami Y; Takemori T; Fujiwara S; Kitayama K; Nishida K; Kuroda R; Akisue T
    BMC Cancer; 2019 Jul; 19(1):725. PubMed ID: 31337342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas.
    Rapkin L; Qayed M; Brill P; Martin M; Clark D; George BA; Olson TA; Wasilewski-Masker K; Alazraki A; Katzenstein HM
    Pediatr Blood Cancer; 2012 Nov; 59(5):854-8. PubMed ID: 22302783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
    Xu J; Guo W; Xie L
    BMC Cancer; 2018 Oct; 18(1):987. PubMed ID: 30326879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer.
    Kountourakis P; Missitzis I; Doufexis D; Zobolas V; Pissakas G; Arnogiannaki N; Maliou S; Sotiropoulou A; Ardavanis A
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):221-8. PubMed ID: 20387073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
    Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
    Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone.
    Palmerini E; Jones RL; Marchesi E; Paioli A; Cesari M; Longhi A; Meazza C; Coccoli L; Fagioli F; Asaftei S; Grignani G; Tamburini A; Pollack SM; Picci P; Ferrari S
    BMC Cancer; 2016 Apr; 16():280. PubMed ID: 27098543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.